semaglutide gastric intestinal obstruction lawsuit in west virginia The U.S. Food and Drug Administration has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, patients who took its GLP-1 medications kentucky semaglutide digestive blockage lawyer

It is a common complication of diabetes, with high blood sugar levels contributing to the buildup of plaques in blood vessels, leading to reduced blood flow and heart function

If you want another overview of how GLP-1 medications support weight management, this guide to GLP-1 weight loss is a helpful next read

Upregulation of autophagy-related proteins (including BCL-1, ATG7, ATG5, and LC3-II) in synovial tissues contributes to synovial fibroblast proliferation, resistance to apoptosis, and chronic inflammatory activation

The most frequently reported adverse effects involve gastrointestinal symptoms, which typically emerge during the initial days to weeks of supplementation as the gut microbiome adjusts to the introduced bacterial strains